Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine’s content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just two segments—the N-terminal domain (NTD) and the receptor binding domain (RBD).
Some of the highlights of the new formula include:
- Improved antigen expression: mRNA-1283 demonstrated improved antigen expression compared to the clinically available mRNA-1273, which encodes the full-length spike protein. This suggests that mRNA-1283 can produce higher levels of the target antigens.
- Enhanced antibody responses: When administered as a primary series, booster, or variant-specific booster, mRNA-1283 elicited similar or greater immune responses than the original mRNA-1273.
- Greater stability: mRNA-1283 showed greater stability at refrigerated temperatures (2° to 8°C). Specifically, mRNA-1283 reached 62% of its initial integrity at 12 months when stored at 2° to 8°C, while the original version reached 63% integrity after only six months under the same conditions, effectively doubling the shelf life.
- Dose-sparing: mRNA-1283 demonstrated the ability to elicit effective immunogenic responses even at lower doses, suggesting the possibility of dose-sparing, which could reduce potential reactogenicity.
- Protection against variants: mRNA-1283, including variant-specific versions, produced more significant neutralizing antibody (nAb) responses against variants such as B.1.351 and B.1.617.2 compared to mRNA-1273, indicating its effectiveness against emerging variants.
Protection in animal models
In animal studies, mice vaccinated with mRNA-1283 were protected from both the D614G mutation and BA.1 variants of SARS-CoV-2, further suggesting that mRNA-1283 can confer protection against different strains of the virus.
Overall, mRNA-1283 offers several advantages, including improved antigen expression, strong immune responses, stability, and dose-sparing, making it a promising candidate for further clinical evaluation as a COVID-19 vaccine.
Early research on the SARS-CoV-2 virus identified the spike protein as a critical component of viral entry into host cells. This knowledge laid the foundation for the original vaccine development by Moderna, which encoded the entire length of the spike protein in the original vaccine formulation.
Researchers have since recognized that not all parts of the spike protein are equally crucial for immune responses. Certain regions, particularly the receptor binding domain (RBD) and the N-terminal domain (NTD), were identified as critical sites for neutralization by antibodies.
Extensive research into the structure and function of the SARS-CoV-2 virus, including its spike protein, provided valuable insights into potential vaccine targets. Scientists used this research to design vaccines specifically focused on the RBD, NTD, or a combination of these domains.
A combination of a deep understanding of the virus, advances in vaccine technology, and rigorous scientific research contributed to the discovery that domain-based vaccines like mRNA-1283 can focus on just the critical antigenic domains of the spike protein.
An effective streamlined and targeted vaccine should also allow for a shorter response time to emerging strains as reformulation efforts only need to focus on the changes of two sites on the virus spike protein.
More information: Guillaume B. E. Stewart-Jones et al, Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2, Science Translational Medicine (2023). DOI: 10.1126/scitranslmed.adf4100
News
Cancer’s Deadly Paradox: How Tumors Break Their Own DNA To Keep Growing
Cancer’s strongest gene switches push DNA into damaging overdrive, creating repeated breaks and repairs that may fuel tumor evolution while exposing possible therapeutic weak spots. A new study indicates that cancer can harm its own genetic [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Ryugu asteroid samples contain all DNA and RNA building blocks, bolstering origin-of-life theories
All the essential ingredients to make the DNA and RNA underpinning life on Earth have been discovered in samples collected from the asteroid Ryugu, scientists said Monday. The discovery comes after these building blocks [...]
Is Berberine Really a “Natural Ozempic”?
Often labeled a “natural Ozempic,” berberine is widely discussed as a metabolic aid. Yet research suggests its influence may lie deeper. In recent years, berberine has gained significant attention as a supposed “natural way” [...]
Viagra Ingredient Shows Promise for Rare Childhood Brain Disease in Surprising Study
A rare childhood disease with no approved treatment may have an unexpected new therapeutic candidate. Sildenafil, the active ingredient also sold under the brand name Viagra, may help reduce symptoms in people with Leigh [...]
In a first for China, Neuracle’s implantable brain-computer interface wins approval
In a landmark development, Neuracle Medical Technology has secured the country’s first-ever approval for an implantable brain-computer interface (BCI) system designed to restore hand motor function in patients with spinal cord injuries, in a [...]
A Cambridge Lab Mistake Reveals a Powerful New Way to Modify Drug Molecules
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development. Researchers at the University of Cambridge have created a new technique for altering complex drug molecules [...]
New book from NanoappsMedical Inc – Molecular Manufacturing: The Future of Nanomedicine
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Scientists Discover Simple Saliva Test That Reveals Hidden Diabetes Risk
Researchers have identified a potential new way to assess metabolic health using saliva instead of blood. High insulin levels in the blood, known as hyperinsulinemia, can reveal metabolic problems long before obvious symptoms appear. It is [...]
One Nasal Spray Could Protect Against COVID, Flu, Pneumonia, and More
A single nasal spray vaccine may one day protect against viruses, pneumonia, and even allergies. For decades, scientists have dreamed of creating a universal vaccine capable of protecting against many different pathogens. The idea [...]
New AI Model Predicts Cancer Spread With Incredible Accuracy
Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread. Why do some tumors spread throughout the body while others remain confined to their [...]
Scientists Discover DNA “Flips” That Supercharge Evolution
In Lake Malawi, hundreds of species of cichlid fish have evolved with astonishing speed, offering scientists a rare opportunity to study how biodiversity arises. Researchers have identified segments of “flipped” DNA that may allow fish to adapt rapidly [...]
Scientists Discover Why Some COVID Survivors Still Can’t Taste Food Years Later
A new study provides the first direct biological evidence explaining why some people continue to experience taste loss long after recovering from COVID-19. Researchers have uncovered specific biological changes in taste buds that could help [...]
Catching COVID significantly raises the risk of developing kidney disease, researchers find
Catching Covid significantly raises the risk of developing deadly kidney disease, research has shown. The virus was found to increase the chances that patients will develop the incurable condition by around 50 per cent. [...]
New Toothpaste Stops Gum Disease Without Harming Healthy Bacteria
Researchers have developed a targeted approach to combat periodontitis without disrupting the natural balance of the oral microbiome. The innovation could reshape how gum disease is treated while preserving beneficial bacteria. The human mouth [...]
